Clinical Trial

Continuous Glucose Monitoring System: Accuracy and Prognostic Value in Critically Ill Patients

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Whether diabetic or non-diabetic patients, blood glucose management during ICU hospitalization is essential. This study aims to evaluate the accuracy of the iCan Continuous Glucose Monitoring (CGM) System for detecting blood glucose levels in ICU patients, as well as its value in prognostic evaluation, to provide reference for blood glucose management in critically ill patients.
Trial Details
NCT Number NCT07108179
Lead Sponsor Sinocare
Conditions Critically Ill Patients
Enrollment 120 participants
Start Date 2025-03-04
Primary Completion 2025-08 (estimated)
Study Completion 2025-09 (estimated)
Updated on ClinicalTrials.gov 2025-08-06